NOVOZYMES A/S/S (OTCMKTS:NVZMY)’s stock price passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $0.00 and traded as high as $46.82. NOVOZYMES A/S/S shares last traded at $46.39, with a volume of 878 shares trading hands.
A number of analysts have commented on the stock. JPMorgan Chase & Co. lowered shares of NOVOZYMES A/S/S from a “neutral” rating to an “underweight” rating in a research note on Tuesday, March 26th. Zacks Investment Research lowered shares of NOVOZYMES A/S/S from a “hold” rating to a “sell” rating in a research note on Thursday, June 20th. One analyst has rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the company. The company presently has an average rating of “Hold” and an average price target of $54.00.
The firm has a market cap of $13.82 billion, a price-to-earnings ratio of 26.59, a P/E/G ratio of 2.13 and a beta of 0.76. The stock’s 50 day simple moving average is $47.32.
Novozymes A/S produces and sells industrial enzymes and microorganisms worldwide. The company offers agriculture solutions, including crop protection, and animal health and nutrition solutions; fermentation, lignecellulosic hydrolysis, liquefaction, process enhancement, and saccharifaction solutions for bioenergy; baking, beverages, dairy, and protein ingredients for the food and beverage industry; and laundry, dishwashing, hand washing, and cleaning solutions for the household care industry.
Further Reading: Hedge Funds
Receive News & Ratings for NOVOZYMES A/S/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NOVOZYMES A/S/S and related companies with MarketBeat.com's FREE daily email newsletter.